New Strategies to improve the Safety of CAR-T Cell Immunotherapy: the imSAVAR Project

被引：0
|
作者：
Alb, M. [1 ]
Einsele, H. [1 ]
Loskill, P. [2 ]
Van der Meer, A. [3 ]
Sewald, K. [4 ]
Reiche, K. [5 ]
Koehl, U. [5 ]
Hudecek, M. [1 ]
机构：
[1] Univ Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] Eberhard Karls Univ Tubingen, Ctr Vitro Models & Alternat Anim Testing 3R, Tubingen, Germany
[3] Univ Twente, Appl Stem Cell Technol, Enschede, Netherlands
[4] Fraunhofer Inst Toxikol & Experimentelle Med ITEM, Hannover, Germany
[5] Fraunhofer Inst Zelltherapie & Immunol IZI, Leipzig, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V246
引用
收藏
页码：70 / 71
页数：2
相关论文
共 50 条
  • [1] NOVEL STRATEGIES TO ENHANCE THE SAFETY OF CAR T CELL IMMUNOTHERAPY: THE IMSAVAR PROJECT
    Alb, M.
    Einsele, H.
    Loskill, P.
    van der Meer, A.
    Sewald, K.
    Reiche, K.
    Koehl, U.
    Hudecek, M.
    CYTOTHERAPY, 2022, 24 (05) : S122 - S122
  • [2] NOVEL STRATEGIES TO ENHANCE THE SAFETY OF CAR T-CELL IMMUNOTHERAPY: THE IMSAVAR PROJECT
    Alb, M.
    Einsele, H.
    Loskill, P.
    Van der Meer, A.
    Sewald, K.
    Reiche, K.
    Koehl, U.
    Hudecek, M.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A12 - A12
  • [3] Novel Strategies to Enhance the safety of CAR T-cell Immunotherapy: The Imsavar Project
    Alb, Miriam
    Moggs, Jonathan
    Wallstabe, Lars
    Hatz, Benedikte
    Einsele, Hermann
    Loskill, Peter
    van der Meer, Andries
    Wagers, Scott
    Koehl, Ulrike
    Hudecek, Michael
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 262 - 263
  • [4] Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
    Miao, Lele
    Zhang, Zhengchao
    Ren, Zhijian
    Tang, Futian
    Li, Yumin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] New Approaches in CAR-T Cell Immunotherapy for Breast Cancer
    Wang, Jinghua
    Zhou, Penghui
    TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 371 - 381
  • [6] Challenges and strategies in relation to effective CAR-T cell immunotherapy for solid tumors
    Yuan, Guangxun
    Ye, Mengke
    Zhang, Yixi
    Zeng, Xun
    MEDICAL ONCOLOGY, 2024, 41 (05)
  • [7] Nanotechnology-Based CAR-T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy
    Wang, Xinyue
    Meng, Fanyan
    Yen, Ying-Tzu
    Li, Rutian
    Liu, Baorui
    ADVANCED FUNCTIONAL MATERIALS, 2021, 31 (01)
  • [8] Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers
    Gu, Xinyu
    Zhang, Yalan
    Zhou, Weilin
    Wang, Fengling
    Yan, Feiyang
    Gao, Haozhan
    Wang, Wei
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [9] Current Strategies to Improve Chimeric Antigen Receptor T (CAR-T) Cell Persistence
    Ghorai, Soren K.
    Pearson, Ashley N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [10] New potential safety signals for CAR-T cell therapies
    Reactions Weekly, 2022, 1916 (1) : 10 - 10
12345